About

Company description

Cambrex is the leading small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Driven by passion, our pharmaceutical products, expertise and technologies accelerate our customers’ small molecule therapeutics into markets across the world. 

  • We put all of our energy and experience into being your partner of choice 
  •  We create value for customers through manufacturing excellence, reliable quality and innovative science 
  •  Our people are the experts that our customers enjoy working with We truly offer our customers an end-to-end partnership for the research, development and manufacture of small molecule therapeutics at every stage of the drug lifecycle.

Quick facts

Affiliated categories: API Contract Manufacturing |Bio Services |Contract Manufacturing More

Upcoming events

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 41C10 Book a meeting See our Exhibitor Profile   See full Exhibitor List
5 may 2020

CPhI North America 2020

5 - 7 May 2020 Philadelphia, USA Visit us at stand 901 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

18 jun 2019

CPhI & PMEC China 2019

18 - 20 June 2019 SNIEC, Shanghai, China We were at stand E1A58 See our Exhibitor Profile   See full Exhibitor List
30 apr 2019

CPhI North America 2019

30 April - 2 May 2019 Chicago, USA We were at stand 1006 See our Exhibitor Profile   See full Exhibitor List
9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 5G12 See our Exhibitor Profile   See full Exhibitor List

News about Cambrex

Cambrex to double size of Edinburgh solid form screening facility

30 Jul 2019

Cambrex to double size of Edinburgh solid form screening facility

The expanded laboratory space will allow the installation of additional instruments and reactors for larger scale crystallization studies and solid form screening capabilities.

Read more

5 Jun 2019

Cambrex completes new process and analytical development facility at Sweden manufacturing site

The process technology laboratories will include new capabilities in the scaling up of potent molecules requiring containment.

Read more

18 Mar 2019

Cambrex completes expansion and manufacturing capability upgrades in Milan

New laboratory has installed a flow chemistry system to allow for continuous manufacturing development.

Read more

2 Jan 2019

Cambrex completes acquisition of Avista Pharma Solutions

Acquisition adds a full complement of early-stage development capabilities to Cambrex’s larger scale capabilities for APIs and finished dosage forms.

Read more